Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 208942
Company: RISING
Company: RISING
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
DOXYCYCLINE | DOXYCYCLINE | EQ 50MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
DOXYCYCLINE | DOXYCYCLINE | EQ 75MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
DOXYCYCLINE | DOXYCYCLINE | EQ 100MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
01/21/2021 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |